Breaking: UN Demands Answers From Namibia on Toxic Legacy of Copper Smelter
Dexcom’s Fatal Flaws
After inaccurate readings from Dexcom’s flagship G7 device, some diabetics are ending up in the ICU — or dead. A surprise FDA inspection revealed Dexcom made an unauthorized design change to a key component of the G7 that internal studies showed was inferior by “every accuracy metric.” Dexcom sold the “adulterated” device anyway. Then several execs fled amid FDA scrutiny, soaring complaints, rising competition, insiders dumping $DXCM, and questionable accounting. Patients are now returning to the G6 or switching to competitors. This investigation reveals Dexcom’s problems are far worse than previously known. It also tackles the mystery: How did a great innovator lose its way — and the trust of diabetics across America?
EXCLUSIVE: Joby hydrogen-powered autonomous aircraft emerges after apparent 9-hour flight
Breaking: Teradyne Tapped For Amazon’s Breakthrough Robot
How Hunterbrook Broke The Big Story
On The B-2s Headed West — And East
Liquidia Drug Approved As Rival United Throws Hail Mary To Delay Actual Launch
Vistra Fights PFAS Testing After Battery Fire
EU Restricts Public Access to Satellite Imagery Over Red Sea
Debris and Missing Wildlife in Nature Reserve After Vistra Battery Fire
Massive American Military Deployment To Middle East With Yemen Conflict Intensifying
Fatal Accident at Universal Stainless Leads Steelworkers To Flag Ongoing Safety Failures
Cartel Crackdown Could Hit Remitly and Western Union
County Silences Reporters as Vistra Dodges Questions About Surface Testing; Later Reverses Course
There’s No New Coronavirus (Just Viral Clickbait)
Vistra Fire Reignites, No Evacuation Ordered
New Data Indicates Elevated Heavy Metal After Vistra Fire
Can The EV Charging Business Survive the Trump Administration?
As PDD Hit by Tariffs, Companies Enabling Chinese Surveillance Remain Nasdaq Listed
VISTRA FIRE DAMAGE CONTROL LED BY FOSSIL FUEL CRISIS FIRM
It seems their best idea is $750 gift cards that residents have called a “joke” and “insult.”
CHINA’S DJI, WORLD’S LARGEST DRONE MANUFACTURER, NO LONGER BLOCKS FLIGHTS OVER AIRPORTS AND MILITARY BASES
Plug Power Appears on Verge of Closing Critical DOE Loan, a Lifeline for the Cash-Strapped Hydrogen Company, Based on DOE Website Change
BrainCo: The “Harvard” Startup That Became A “Little Dragon” in China — With Brain Data From U.S. Olympians and Schoolchildren
Poisoned USA: Hastings, NE
How Western Tech Powers Russia’s War Against Ukrainian Civilians
“House from Hell” — How America’s Largest Homebuilders Shift the Cost of Shoddy Construction to Buyers
Cracking Big Egg: Why the Industry’s Narrative Doesn’t Add Up
After Vistra Fire, Residents Report Illness, Scientists Confirm Contaminated Soil
RH: Where Did All The Cash Go?
Schrödinger: The Nvidia Biotech Partner Jensen Huang Told To “Think Bigger”
FDA Heads to Court to Defend Unprecedented Decision Protecting Lung Drug Monopoly From Liquidia Competition
Plug Power Failure Part II: Is Plug The Next Solyndra? Accounting Analysis Reveals Dwindling Cash, Collapse of Margins, And Unprofitable Fuel Deliveries, Indicating Company May Not Be Able To Pay Back The DOE
Plug Power Failure Part I: Critical DOE Loan at Risk Due To False Water Data, Cash Crunch, And Stalled Expansions As Hostile Trump Administration Looms
Universal Stainless, Set To Be Acquired, Behind Fatal Bell Boeing Osprey Crash
“WE’VE GOT A LOT OF PEOPLE KILLED HERE”
ESSENTIAL NODE IN GLOBAL SEMICONDUCTOR SUPPLY CHAIN HIT BY HURRICANE HELENE — COMPANY SAYS IT HAS “TEMPORARILY HALTED OPERATIONS” AFTER VIDEO REVEALS ENTRANCE TO MINE HAS FLOODED
CAVA: FILTH FLIES, “C” SANITATION GRADES, FDA LISTERIA SWABS, SNEAKY SEED OIL, INSIDER SELLING, AND THE DIARRHETIC FALLOUT OF FAST GROWTH
“Grand Deception” — Winnebago Muzzles Outcry Over Major Problem That Owners Say Makes RVs Dangerous, Untowable, Worthless
The Struggling AI Bet Behind Softbank’s Grocery Gamble
Coal, Crypto, and False Branding: Inside TeraWulf’s Greenwashing Machine
Fission Impossible: Nano Nuclear Has No Revenue, No Products, “Laughable” Timelines, Part-Time Executives, and a $600 Million Market Cap
Free Newsletter Sign Up
Breaking News & Investigations.
Right to Your Inbox.
No Paywalls.
No Ads.